
Explore contributions, investments and results in our fight against AIDS, tuberculosis and malaria around the world.
Approved by the Board on: 04 September 2009
The Board:
| Constituency | Name | Role | |
| Leadership | |||
| 1 | Private Foundations | Dai Ellis Executive Vice President, Access Programs, Clinton HIV/AIDS Initiative | Chair |
| 2 | UNAIDS | Shanelle Hall Director, Supply Division, UNICEF | Vice-Chair |
| Donor | |||
| 3 | Private Sector | Ian Boulton Managing Director, TropMed Pharma Consulting | Member |
| 4 | Point 7 | Turid Kongsvik Counselor, Norwegian Permanent Mission to the Council of Europe | Member |
| 5 | United Kingdom | Saul Walker Senior Policy Adviser (Access to Medicines), DFID, (AIDS expert) | Member |
| 6 | United States | Mike Hope Senior Pharmacist, Office of HIV/AIDS, USAID | Member |
| Implementer | |||
| 7 | Western and Central Africa | Lazare Bansse General Manager, Central Purchasing of Essential and Generic Drugs, Burkina Faso and Permanent Secretary, Association of Central Purchasing of Essential Drugs, Africa | Member |
| 8 | Latin America and the Caribbean | Carl Browne Director, Pan Caribbean Partnership Against HIV/AIDS | Member |
| 9 | Developed Country NGOs | Mohga Kamal-Yanni Senior Health and HIV Policy Advisor, Oxfam | Member |
| 10 | Eastern Europe | Tonka Varleva, Secretary, National Committee for Prevention of AIDS and STIs, Bulgaria | Member |
| 11 | Western Pacific | Lin-hua Tang Director, National Institute of Parasitic Disease, China, (malaria expert) | Member |
| Non-voting member | |||
| 12 | WHO | Rob Matiru Chief of Operations, Global Drug Facility, (TB expert) | Member |
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website. To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.